Norge -
norsk -
Statens legemiddelverk
zocor 40 mg
orifarm as - simvastatin - tablett, filmdrasjert - 40 mg
Norge -
norsk -
Statens legemiddelverk
zocor 40 mg
orifarm as - simvastatin - tablett, filmdrasjert - 40 mg
Den europeiske union -
norsk -
EMA (European Medicines Agency)
poteligeo
kyowa kirin holdings b.v. - mogamulizumab - sezary syndrome; mycosis fungoides - antineoplastiske midler - poteligeo er indisert for behandling av voksne pasienter med mycosis fungoides (mf) eller sézary syndrom (ss) som har mottatt minst én tidligere systemisk terapi.
Norge -
norsk -
Statens legemiddelverk
inegy 10 mg / 20 mg
orifarm as - ezetimib / simvastatin - tablett - 10 mg / 20 mg
Norge -
norsk -
Statens legemiddelverk
inegy 10 mg / 40 mg
orifarm as - ezetimib / simvastatin - tablett - 10 mg / 40 mg
Norge -
norsk -
Statens legemiddelverk
vemlidy 25 mg
orifarm as - tenofoviralafenamidfumarat - tablett, filmdrasjert - 25 mg
Norge -
norsk -
Statens legemiddelverk
inegy 10 mg / 20 mg
2care4 aps - ezetimib / simvastatin - tablett - 10 mg / 20 mg
Norge -
norsk -
Statens legemiddelverk
vemlidy 25 mg
abacus medicine a/s - tenofoviralafenamidfumarat - tablett, filmdrasjert - 25 mg
Den europeiske union -
norsk -
EMA (European Medicines Agency)
onureg
bristol-myers squibb pharma eeig - azacitidin - leukemi, myeloid, akutt - antineoplastiske midler - onureg is indicated as maintenance therapy in adult patients with acute myeloid leukaemia (aml) who achieved complete remission (cr) or complete remission with incomplete blood count recovery (cri) following induction therapy with or without consolidation treatment and who are not candidates for, including those who choose not to proceed to, hematopoietic stem cell transplantation (hsct).
Norge -
norsk -
Statens legemiddelverk
ezetimibe/simvastatin accord 10 mg / 20 mg
accord healthcare b.v. - ezetimib / simvastatin - tablett - 10 mg / 20 mg